RxDoctor Payments Data

Casey Browning, NP

Nurse Practitioner · Indianapolis, INNPI 1689009441

Payments from drug & device makers

$739in general payments, 2019–2025

Across 33 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$179
  • AstraZeneca$104
  • Abbott$68
  • Novartis$64
  • E.r. Squibb & Sons, L.L.C.$48
  • Merck$45
  • plus $230 from 9 others

What the payments were for

  • Food & beverage$739100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$739 in reported general payments places this provider in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$43,754
Medicare patients
344
Services billed
578

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban104$136,606
EntrestoSacubitril/Valsartan58$71,048
JardianceEmpagliflozin57$68,003
XareltoRivaroxaban22$31,766
FarxigaDapagliflozin Propanediol19$19,239
OzempicSemaglutide12$10,002
Potassium Chloride80$5,644
Metoprolol Succinate122$1,198
Carvedilol133$1,065
Torsemide57$932
Midodrine Hcl13$824
Diltiazem 24hr Er (Cd)Diltiazem Hcl23$752
Losartan Potassium111$644
Klor-Con M20Potassium Chloride25$613
Amiodarone Hcl14$547

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$136,606104 claims
NovartisEntresto$64$71,04858 claims
AstraZenecaFarxiga$104$19,23919 claims
Novo NordiskOzempic$179$10,00212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →